Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Rapid Administration of Carnitine in sEpsis

ClinicalTrials.gov ID: NCT01665092

Public ClinicalTrials.gov record NCT01665092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Study of Levo-Carnitine for Vasopressor Dependent Septic Shock

Study identification

NCT ID
NCT01665092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Mississippi Medical Center
Other
Enrollment
250 participants

Conditions and interventions

Conditions

Interventions

  • Levo-Carnitine Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2012
Primary completion
Feb 28, 2018
Completion
Feb 28, 2019
Last update posted
Jun 3, 2019

2013 – 2019

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama
Univeristy of California Davis Sacramento California
Christiana Care Health Services Wilmington Delaware
University of Florida Jacksonville Florida
Northwestern University Chicago Illinois
Indiana University Indianapolis Indiana
BIDMC Boston Massachusetts
BWH Boston Massachusetts
MGH Boston Massachusetts
St. Vincent Hospital Worcester Massachusetts
Wayne State University Detroit Michigan
University of Mississippi Medical Center Jackson Mississippi 29316
Cooper University Hospital Camden New Jersey
Carolinas Medical Center Charlotte North Carolina

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01665092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01665092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →